FDA Approves Medinol’s PioNIR Plus Atent

Medinol has received approval from the US Food and Drug Administration (FDA) to sell its PioNIR Plus stent. This is on the basis of the results of a comprehensive trial of the product that was completed a year ago. The PioNIR Plus stent, also sold under the name Presillion Plus, is a stent developed by Medinol for coronary arteries. It is of the ‘bare metal’ type, meaning the stents are not coated with medication.